Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Abstract 818: New targets in prostate cancer: Nuclear localization of galectin-1 in androgen receptor indifferent prostate cancer

Maria Malvina Tsamouri, Salma Siddiqui, Blythe P. Durbin-Johnson, Kit S. Lam, Ruiwu Liu, Paramita M. Ghosh

Cancer Res (2022) 82 (12_Supplement): 818.

https://doi.org/10.1158/1538-7445.AM2022-818

Published: 15 June 2022

View article titled, Abstract 818: New targets in prostate cancer: Nuclear localization of galectin-1 in androgen receptor indifferent prostate cancer

Journal Articles

Abstract 4649: Targeting the cancer cell lysosome with transformable self-assembling peptide nanoparticles

Christopher M. Baehr, Lei Wang, Kit S. Lam

Cancer Res (2018) 78 (13_Supplement): 4649.

https://doi.org/10.1158/1538-7445.AM2018-4649

Published: 01 July 2018

View article titled, Abstract 4649: Targeting the cancer cell lysosome with transformable self-assembling peptide nanoparticles

Journal Articles

Abstract 4860: A novel class of small-molecule inhibitors of galectin-1 for prostate cancer therapy

Ruiwu Liu, Tsung-Chieh Shih, Sophie Kiss, Xiaocen Li, Ting Wang, Jonathan S. Huynh, Chun-Te Wu, Yong Duan, Paramita M. Ghosh, Kit S. Lam

Cancer Res (2018) 78 (13_Supplement): 4860.

https://doi.org/10.1158/1538-7445.AM2018-4860

Published: 01 July 2018

View article titled, Abstract 4860: A novel class of small-molecule inhibitors of galectin-1 for prostate cancer therapy

Journal Articles

Abstract 3717: α₃β₁-Integrin targeted DM1 micellar prodrug for targeted therapy against ovarian cancer

Xiaocen Li, Wenwu Xiao, Yayu Wang, Xiaojia Chen, Ruiwu Liu, Kit S. Lam

Cancer Res (2018) 78 (13_Supplement): 3717.

https://doi.org/10.1158/1538-7445.AM2018-3717

Published: 01 July 2018

View article titled, Abstract 3717: α3β1-Integrin targeted DM1 micellar prodrug for targeted therapy against ovarian cancer

Journal Articles

Abstract 1344: Novel targeting all-in-one nanoporphyrin platform against bladder cancer

Yuanpei Li, Tzu-yin Lin, Chongxian Pan, Kit S. Lam

Cancer Res (2016) 76 (14_Supplement): 1344.

https://doi.org/10.1158/1538-7445.AM2016-1344

Published: 15 July 2016

View article titled, Abstract 1344: Novel targeting all-in-one nanoporphyrin platform against bladder cancer

Journal Articles

Abstract 4226: The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

Xinlei Wang, Wenwu Xiao, Yuanpei Li, Pengfei Zhang, Mayank Goswami, Robert J. Zawadzki, Edward N. Pugh, Kit S. Lam

Cancer Res (2016) 76 (14_Supplement): 4226.

https://doi.org/10.1158/1538-7445.AM2016-4226

Published: 15 July 2016

View article titled, Abstract 4226: The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

Journal Articles

Abstract 4508: Novel multifunctional nanocarriers for drug delivery, photodynamic therapy, sonodynamic therapy, MRI and PET imaging.

Kit S. Lam, Yuanpei Li, Tzu-yin Lin, Hongyong Zhang, Caihong Feng, Yan Luo, Chong-Xian Pan, Kai Xiao, Wenwu Xiao, Joyce Lee, Ruiwu Liu

Cancer Res (2013) 73 (8_Supplement): 4508.

https://doi.org/10.1158/1538-7445.AM2013-4508

Published: 15 April 2013

View article titled, Abstract 4508: Novel multifunctional nanocarriers for drug delivery, photodynamic therapy, sonodynamic therapy, MRI and PET imaging.

Journal Articles

“OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo

Kai Xiao, Yuanpei Li, Joyce S. Lee, Abby M. Gonik, Tiffany Dong, Gabriel Fung, Eduardo Sanchez, Li Xing, Holland R. Cheng, Juntao Luo, Kit S. Lam

Cancer Res (2012) 72 (8): 2100–2110.

https://doi.org/10.1158/0008-5472.CAN-11-3883

Published: 16 April 2012

View article titled, “OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo

Includes: Supplementary data

Journal Articles

Abstract 1943: On-demand reversible boronate-catechol crosslinked nanocarriers for cancer therapy

Kit S. Lam, Yuanpei Li, Kai Xiao, Wenwu Xiao, Juntao Luo

Cancer Res (2012) 72 (8_Supplement): 1943.

https://doi.org/10.1158/1538-7445.AM2012-1943

Published: 15 April 2012

View article titled, Abstract 1943: On-demand reversible boronate-catechol crosslinked nanocarriers for cancer therapy

Journal Articles

Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma

Ruiwu Liu, Wenwu Xiao, Fernanda C. Bononi, Eduardo Sanchez, Yanlei Liu, Anisha Mazloom, Harry Tseng, Kit S. Lam

Cancer Res (2012) 72 (8_Supplement): 368.

https://doi.org/10.1158/1538-7445.AM2012-368

Published: 15 April 2012

View article titled, Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma

Journal Articles

Abstract 378: Multifunctional bladder cancer targeting micelle nanocarriers with both imaging and therapeutic potentials

Tzu-yin Lin, Juntao Luo, Hongyong Zhang, Yuanpei Li, Tingjuan Gao, Ralph de Vere Whtie, Kit S. Lam, Chong-Xian Pan

Cancer Res (2012) 72 (8_Supplement): 378.

https://doi.org/10.1158/1538-7445.AM2012-378

Published: 15 April 2012

View article titled, Abstract 378: Multifunctional bladder cancer targeting micelle nanocarriers with both imaging and therapeutic potentials

Journal Articles

Abstract 3488: Targeting ligands and nanotherapeutics against acute myeloid leukemia stem cell

Hongyong Zhang, Juntao Luo, Yuanpei Li, Paul T Henderson, Yanchun Wang, Sebastian Wachsmann-Hogiu, Kit S. Lam, Chongxian Pan

Cancer Res (2012) 72 (8_Supplement): 3488.

https://doi.org/10.1158/1538-7445.AM2012-3488

Published: 15 April 2012

View article titled, Abstract 3488: Targeting ligands and nanotherapeutics against acute myeloid leukemia stem cell

Journal Articles

Abstract 5724: HER2-mediated resistance of breast cancer stem cells in HER2-negative/low breast cancer

Demet Candas, Ming Fan, Nadire Duru, Cheikh Menaa, Yunfei Wen, Kai Xiao, Angela Eldridge, Brett A. Chromy, Shiyong Li, Douglas R. Spitz, Kit S. Lam, Max S. Max, Jian Jian Li

Cancer Res (2012) 72 (8_Supplement): 5724.

https://doi.org/10.1158/1538-7445.AM2012-5724

Published: 15 April 2012

View article titled, Abstract 5724: HER2-mediated resistance of breast cancer stem cells in HER2-negative/low breast cancer

Journal Articles

Abstract 3245: Novel anticancer agents – lead discovery and optimization

Liping Meng, Don-Hong Wang, Chun-Yi Wu, Kit S. Lam

Cancer Res (2011) 71 (8_Supplement): 3245.

https://doi.org/10.1158/1538-7445.AM2011-3245

Published: 15 April 2011

View article titled, Abstract 3245: Novel anticancer agents – lead discovery and optimization

Journal Articles

Abstract 3580: Discovery and SAR study of a novel and potent Itk inhibitor as a targeted therapeutic agent for T-cell lymphoma and leukemia

Ruiwu Liu, Wenchang Guo, Aihong Ma, Eduardo Sanchez, Yan Wang, Jixian Li, Chunping Xu, Jinying Ning, Wenzhe Huang, Anisha Mazloom, Aimin Song, Kit S. Lam, Michelle Xia, Yiyou Chen, Hsing-Jien Kung

Cancer Res (2011) 71 (8_Supplement): 3580.

https://doi.org/10.1158/1538-7445.AM2011-3580

Published: 15 April 2011

View article titled, Abstract 3580: Discovery and SAR study of a novel and potent Itk inhibitor as a targeted therapeutic agent for T-cell lymphoma and leukemia

Journal Articles

Abstract 366: Novel self-folding tricyclic cholic acid-peptide hybrids as nanotherapeutic ligands targeting prostate and breast cancers and human embryonic stem cells

David J. Olivos, Mary R. Saunders, Yoshiko Maeda, Kit S. Lam

Cancer Res (2011) 71 (8_Supplement): 366.

https://doi.org/10.1158/1538-7445.AM2011-366

Published: 15 April 2011

View article titled, Abstract 366: Novel self-folding tricyclic cholic acid-peptide hybrids as nanotherapeutic ligands targeting prostate and breast cancers and human embryonic stem cells

Journal Articles

Abstract 4448: Rational design of a novel nanocarrier for doxorubicin delivery in cancer treatment

Juntao Luo, Kai Xiao, Joyce S. Lee, Yuanpei Li, Kit S. Lam

Cancer Res (2011) 71 (8_Supplement): 4448.

https://doi.org/10.1158/1538-7445.AM2011-4448

Published: 15 April 2011

View article titled, Abstract 4448: Rational design of a novel nanocarrier for doxorubicin delivery in cancer treatment

Journal Articles

Abstract 4439: A reversibly self-crosslinking nano-carrier system for efficient anticancer drug delivery

Yuanpei Li, Kai Xiao, Juntao Luo, Wenwu Xiao, Joyce Lee, Kit S. Lam

Cancer Res (2011) 71 (8_Supplement): 4439.

https://doi.org/10.1158/1538-7445.AM2011-4439

Published: 15 April 2011

View article titled, Abstract 4439: A reversibly self-crosslinking nano-carrier system for efficient anticancer drug delivery

Journal Articles

Abstract 4447: Nanoformulation of lapatinib for HER2-positive breast cancer patients with brain metastasis

Joyce S. Lee, Juntao Luo, Sonal Desai, Kit S. Lam, Tianhong Li

Cancer Res (2011) 71 (8_Supplement): 4447.

https://doi.org/10.1158/1538-7445.AM2011-4447

Published: 15 April 2011

View article titled, Abstract 4447: Nanoformulation of lapatinib for HER2-positive breast cancer patients with brain metastasis

Journal Articles

Abstract 5311: The targeting effect of radio-labeled LXY1 and LXW7 against glioblastoma on xenograft mouse model

Wenwu Xiao, Ruiwu Liu, Nianhuan Yao, Kit S. Lam

Cancer Res (2011) 71 (8_Supplement): 5311.

https://doi.org/10.1158/1538-7445.AM2011-5311

Published: 15 April 2011

View article titled, Abstract 5311: The targeting effect of radio-labeled LXY1 and LXW7 against glioblastoma on xenograft mouse model

NARROW

Abstract 818: New targets in prostate cancer: Nuclear localization of galectin-1 in androgen receptor indifferent prostate cancer

Abstract 4649: Targeting the cancer cell lysosome with transformable self-assembling peptide nanoparticles

Abstract 4860: A novel class of small-molecule inhibitors of galectin-1 for prostate cancer therapy

Abstract 3717: α₃β₁-Integrin targeted DM1 micellar prodrug for targeted therapy against ovarian cancer

Abstract 1344: Novel targeting all-in-one nanoporphyrin platform against bladder cancer

Abstract 4226: The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

Abstract 4508: Novel multifunctional nanocarriers for drug delivery, photodynamic therapy, sonodynamic therapy, MRI and PET imaging.

“OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo

Abstract 1943: On-demand reversible boronate-catechol crosslinked nanocarriers for cancer therapy

Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma

Abstract 378: Multifunctional bladder cancer targeting micelle nanocarriers with both imaging and therapeutic potentials

Abstract 3488: Targeting ligands and nanotherapeutics against acute myeloid leukemia stem cell

Abstract 5724: HER2-mediated resistance of breast cancer stem cells in HER2-negative/low breast cancer

Abstract 3245: Novel anticancer agents – lead discovery and optimization

Abstract 3580: Discovery and SAR study of a novel and potent Itk inhibitor as a targeted therapeutic agent for T-cell lymphoma and leukemia

Abstract 366: Novel self-folding tricyclic cholic acid-peptide hybrids as nanotherapeutic ligands targeting prostate and breast cancers and human embryonic stem cells

Abstract 4448: Rational design of a novel nanocarrier for doxorubicin delivery in cancer treatment

Abstract 4439: A reversibly self-crosslinking nano-carrier system for efficient anticancer drug delivery

Abstract 4447: Nanoformulation of lapatinib for HER2-positive breast cancer patients with brain metastasis

Abstract 5311: The targeting effect of radio-labeled LXY1 and LXW7 against glioblastoma on xenograft mouse model

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only